Healthcare provider profile · identity verified

Beth Fisher, DO

Family Practice · MIDDLETOWN, DE · NPI 1689651747

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	561	168
Amlodipine Besylate	Amlodipine Besylate	379	108
Losartan Potassium	Losartan Potassium	291	85
Lisinopril	Lisinopril	261	76
Omeprazole	Omeprazole	232	67
Levothyroxine Sodium	Levothyroxine Sodium	210	66
Hydrochlorothiazide	Hydrochlorothiazide	192	54
Rosuvastatin Calcium	Rosuvastatin Calcium	185	49
Metformin Hcl	Metformin Hcl	182	56
Metoprolol Succinate	Metoprolol Succinate	132	39
Gabapentin	Gabapentin	103	35
Sertraline Hcl	Sertraline Hcl	99	27
Escitalopram Oxalate	Escitalopram Oxalate	98	31
Carvedilol	Carvedilol	87	21
Alendronate Sodium	Alendronate Sodium	83	27
Simvastatin	Simvastatin	81	24
Furosemide	Furosemide	72	14
Albuterol Sulfate Hfa	Albuterol Sulfate	65	31
Pravastatin Sodium	Pravastatin Sodium	65	18
Duloxetine Hcl	Duloxetine Hcl	60	15
Bupropion Xl	Bupropion Hcl	56	16
Montelukast Sodium	Montelukast Sodium	53	14
Fluticasone Propionate	Fluticasone Propionate	51	20
Trazodone Hcl	Trazodone Hcl	51	14
Metformin Hcl Er	Metformin Hcl	48	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	13
Synthroid	Levothyroxine Sodium	45	12
Chlorthalidone	Chlorthalidone	44	13
Buspirone Hcl	Buspirone Hcl	40	16
Mirtazapine	Mirtazapine	35	suppressed
Potassium Chloride	Potassium Chloride	35	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	32	suppressed
Valsartan	Valsartan	32	11
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	14
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Mounjaro	Tirzepatide	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Ozempic	Semaglutide	26	suppressed
Eliquis	Apixaban	25	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Alprazolam	Alprazolam	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Irbesartan	Irbesartan	20	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Atenolol	Atenolol	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	12
Lorazepam	Lorazepam	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Cephalexin	Cephalexin	13	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Famotidine	Famotidine	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Livalo	Pitavastatin Calcium	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	11
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error